Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last C$27.82 CAD
Change Today +0.12 / 0.43%
Volume 4.0K
TR On Other Exchanges
As of 2:06 PM 06/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Henry G. Friesen C.C., M.D., F.R.S.C.

Director, Chairman of Corporate Governance & Nominating Committee and Member of Audit Committee, Trillium Therapeutics Inc.
AgeTotal Calculated CompensationThis person is connected to 34 board members in 4 different organizations across 3 different industries.

See Board Relationships


Dr. Henry G. Friesen, C.C., M.D., F.R.S.C serves as a Distinguished Professor Emeritus, University of Manitoba. Dr. Friesen served as the President of the Medical Research Council of Canada from 1991 to 2000. He served as the Architect and driving force behind a bold new vision for Canadian health research through the formation of the Canadian Institutes of Health Research. He served as Chairman of Genome Canada since 2000 until 2005. He has been a Director of YM Biosciences ...

Read Full Background

Corporate Headquarters*

96 Skyway Avenue
Toronto, Ontario M9W 4Y9


Phone: 416-595-0627
Fax: --

Board Members Memberships*

Director and Member of Audit Committee
Former Director, Chairman of Nomination & Governance Committee and Member of Human Resources & Compensation Committee
Director, Chairman of Corporate Governance & Nominating Committee and Member of Audit Committee


Unknown/Other Education
University of Manitoba
University of Manitoba

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

Total Value of OptionsC$13,365
Total Number of Options6,167

Total Compensation*

Total Annual Cash CompensationC$58,000
Total Calculated CompensationC$98,000
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TR:CN C$27.82 CAD +0.12


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TRILLIUM THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at